Commonwealth Equity Services’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,673
Closed -$158K 4433
2025
Q2
$158K Buy
+13,673
New +$125K ﹤0.01% 3980
2025
Q1
Sell
-10,137
Closed -$146K 4288
2024
Q4
$146K Buy
+10,137
New +$160K ﹤0.01% 3836
2024
Q2
Sell
-5,526
Closed -$207K 4173
2024
Q1
$207K Sell
5,526
-30
-0.5% -$1.32K ﹤0.01% 3598
2023
Q4
$311K Sell
5,556
-1,637
-23% -$71.2K ﹤0.01% 3139
2023
Q3
$297K Buy
7,193
+1,486
+26% +$77.3K ﹤0.01% 3042
2023
Q2
$319K Sell
5,707
-323
-5% -$17.5K ﹤0.01% 2998
2023
Q1
$336 Sell
6,030
-1,498
-20% -$70K ﹤0.01% 2864
2022
Q4
$274K Sell
7,528
-30
-0.4% -$981 ﹤0.01% 2944
2022
Q3
$215K Sell
7,558
-24
-0.3% -$914 ﹤0.01% 3107
2022
Q2
$343K Sell
7,582
-1,684
-18% -$87.4K ﹤0.01% 2720
2022
Q1
$704K Sell
9,266
-147
-2% -$12.9K ﹤0.01% 2258
2021
Q4
$1.4M Buy
9,413
+47
+0.5% +$7.2K ﹤0.01% 1742
2021
Q3
$1.36M Sell
9,366
-1,626
-15% -$279K ﹤0.01% 1704
2021
Q2
$2.15M Sell
10,992
-7
-0.1% -$1.27K 0.01% 1376
2021
Q1
$1.99M Buy
10,999
+693
+7% +$120K 0.01% 1327
2020
Q4
$1.46M Buy
10,306
+240
+2% +$34.8K ﹤0.01% 1414
2020
Q3
$1.25M Buy
+10,066
New +$1.06M ﹤0.01% 1362

Other funds holding TXG

Commonwealth Equity Services's TXG Position: Q3 2025 in Review

Commonwealth Equity Services sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 13,673 shares — an estimated $158K sold.

Commonwealth Equity Services first reported a position in TXG in Q3 2020 and held it in 17 quarters. The position peaked at $2.15M in Q2 2021. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Commonwealth Equity Services reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 13,673 10x Genomics shares in Q3 2025, an estimated $158K.
  • Commonwealth Equity Services first reported a position in 10x Genomics in Q3 2020 and held it in 17 quarters.
  • Commonwealth Equity Services's 10x Genomics position peaked at $2.15M in Q2 2021.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.